Wir schließen die Lücke zwischen wissenschaftlichem Potenzial und Versorgungspraxis

From defining active ingredients to providing care, we orchestrate the entire value chain. Each discipline – from raw materials to patient care – is managed by an independent, specialized company. This ensures clear lines of responsibility, regulatory compliance, and economic scalability.

Strategy

MediFirst Invest: Holding, Capital Allocation & Real Estate

Origin & Innovation (Switzerland)

Innuana AG: Research platform & translation of preclinical data.
Grow Art AG: Competence center for genetics & process specifications.

Science & Development (Germany)

MediFirst R&D: Drug research and clinical trials up to series production.
MediFirst Biotech: Pharmaceutical formulation, extraction processes, and innovative dosage forms.

Operations & Infrastructure (Germany)

MediFirst Pharma: Manufacturing, import & pharmaceutical wholesale (§ 52a AMG).
MediFirst Supply: Medical technology & infrastructure (hardware/diagnostics).

Market & Care Delivery (Germany)

MediFirst Commerce: Strategic B2B Sales & Training.
MediFirst Medicum: Medical Care Center & Structured Evidence Processes (Real-World Evidence).
MediFirst NPO: Science Communication, Advocacy & Education

Ein lernendes System für bessere Medizin

Quality doesn't end at the point of sale for us. We've established a closed-loop system: Structured supply and quality data are fed back into research and quality processes in compliance with GDPR, for specific purposes, and with governance support. This allows us to continuously develop standards and evidence in a transparent and compliant manner.

Discover the corporate structureContact us now